Gedivumab

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGedivumab

Drug Alias NameRG-7745MHAA-4549A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionImmunomodulatorsInfluenza virus hemagglutinin glycoproteins inhibitors

TargetsInfluenza virus hemagglutinin glycoproteins

Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumBulgaria +[26]

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsInfluenza A virus infectionsInfluenza, Human

ATC CodeN/A